References
- Boezio B, Audouze K, Ducrot P, Olivier T. 2017. Network-based approaches in pharmacology. Mol Inform. 36(10):1868–1751.
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
- Chen WN, Wang JY, Jia LQ, Cong PW, Sun HW. 2015. Active part of Achyranthes Promotes maturation and regulates the functions of DC in tumor microenvironment. Chin Pharm J. 50(23):2051–2056.
- Gyu LS, Eun JL, Woo DP, Jong BK, Eun OK, Sang WC. 2012. Anti-inflammatory and anti-osteoarthritis effects of fermented Achyranthes japonica Nakai. J Ethnopharmacol. 142(3):634–641.
- Han ZY, Niu YY. 2007. An overview of the study of Achyranthes bidentata. Chin Pharm. 15:64–66.
- Hu J, Qi YX, Li QX, Shan BE. 2005. The research of extract of Achyranthes bidentata Blume’s anti-tumor activity. Chin J Microbiol Immunol. 25:415–418.
- Liu Y, Jiang H, Yan ML, Xing XD, Zhang YY, Wei N. 2017. A new phytoecdysteroid from the roots of Achyranthes bidentata Bl. Nat Prod Res. 31(9):1.
- Martins A, Tóth N, Ványolós A, Béni Z, Zupkó I, Molnár J, Báthori M, Hunyadi A. 2012. significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 Transporter. J Med Chem. 55(11):5034–5043.
- Wang XY, Wang MC, Xu M, Wang Y, Tang HF, Sun XL. 2014. Cytotoxic oleanane-type triterpenoid saponins from the rhizomes of Anemone rivularis var. flore-minore. Molecules. 19(2):2121– 3049.
- Yang L, Yan ML, Wu LH, Jiang H. 2016. Investigation of radix Achyranthes bidentata phytochemistry and pharmacology. Inform Trad Chin Med. 33(6):8–11.